WideCells Group PLC launch Wideacademy and targeting growth and commercial roll-out

WideCells Group PLC LON:WDC, the healthcare services group focused on providing stem cell services and ground-breaking insurance for stem cell treatment, this morning announced a number of corporate developments.

WideCells Group CEO, João Andrade, said, “We are delighted to welcome David Henriques to the Board.  His extensive corporate finance experience and knowledge of digitalisation in the insurance industry will be invaluable to us as we continue to build the profile of our company.  WideCells Group was founded to provide an end-to-end stem cell service having early identified a number of market opportunities.

 Our sights are now on growth and commercial roll-out.  In support of this, we have identified significant development opportunities in the Asia-Pacific territories, where the stem cell industry is gaining increasing profile.  Furthermore, we are delighted to have launched our Wideacademy platform, which we believe will support both stem cell storage and treatment uptake, and the development of the industry as a whole.  Wideacademy, together with our stem cell insurance product, CellPlan, are the first products of their kind, and it is our ability to recognise industry limitations and find solutions to overcome them, which I believe sets us apart and puts us on the path for significant growth.”

 

·     David Henriques has been appointed to the board as a Non-Executive Director:

o  Mr Henriques has significant asset management and corporate finance experience, and is involved with the digitalisation of insurance products

o  As part of this appointment, Mr. Zakaria Aziz will be stepping down from his Non-Executive position.

 

·     Wideacademy, the Group’s 100% owned education and training division, has successfully launched the first stage of www.wideacademy.co:

o  Provides educational content for both the public and medical professionals to raise the profile of stem cell technologies and support the development of the industry.

o  Platform combines free-to-access educational areas with paid for premium digital tools and resources for doctors/medical professionals

 

·     With a strengthened board and three active divisions, the Group’s primary focus is now on building its global profile, increasing client reach and driving sales of its stem cell services:

o  Identified new opportunities within Asia-Pacific region

o  E-commerce site now live for INDUS and product development continues with minimal additional capital outlay and management resources

 Mr. David Henriques has been appointed to the Board as Non-Executive Director.  His appointment will enable the Group to separate the functions of Group Chairman from that of Chairman of the Audit & Risk Committee. Mr Henriques will act as Chairman of the Group’s Audit & Risk Committee, while Mr. Peter Presland will continue as Group Chairman.  

 

As an experienced corporate financier who is involved with the digitalisation of insurance products, Mr. Henriques brings a unique skill set to support the continued growth of WideCells Group.   He is a co-Founder and Director of Cairn Capital Ltd , a full-service credit asset management firm, and was formerly co-Global Head of Structured Credit Products with the Royal Bank of Scotland.  Prior to this, he held various senior positions in corporate finance and insurance companies.  He is currently a Non-Executive Director of Azur Group Holdings Limited, an Insurance Managing Digital Agency, which partners with carriers and brokers to build, underwrite and distribute digital insurance products.

Click to view all articles for the EPIC:
Or click to view the full company profile:
    Facebook
    Twitter
    LinkedIn
    WideCells Group PLC

    More articles like this

    WideCells Group PLC

    Umbilical blood injects new life into 8-month-old baby

    An 8-month-old girl who had severe combined immune deficiency (SCID) underwent a successful hematopoietic stem cell transplant surgery in Shanghai. The stem cell was taken from umbilical cord blood. Widecells Group PLC (LON:WDC) are leading a

    WideCells Group PLC

    Leukaemia: A Guide To The Cancer Of The Blood

    It is not hereditary, and it is not contagious. It is, however, one of the diseases that kills more children than many others. The word ‘leukaemia’ refers to a group of cancers that spread through the

    WideCells Group PLC

    Autism Treated With Stem Cells

    Researchers at Duke University have utilized autologous (the patient’s own) stem cell infusions to promote increased connectivity in the brain that allowed for improved communication and language abilities in children with Autism Spectrum Disorder (ASD). The

    WideCells Group PLC

    Cord blood banking industry expected to grow

    The list of decisions for new parents already seems endless but it continues to grow as new advances in medicine and technology open new doors for healthcare. Many private companies offer services for collecting and storing